1 day Ago By Defense World Staff
Analysts at StockNews.com started coverage on shares of Mannatech ( NASDAQ:MTEX – Get Free Report ) in a research report issued on Monday. The brokerage set a “buy” rating on the stock.
Mannatech Price Performance Shares of NASDAQ MTEX opened at $8.05 on Monday. Mannatech has a 1 year low of $6.
75 and a 1 year high of $10.51. The stock has a market capitalization of $15.
13 million, a P/E ratio of -9.94 and a beta of 1.17.
The company’s 50-day moving average is $7.78 and its 200 day moving average is $7.54.
The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.
74. Mannatech ( NASDAQ:MTEX – Get Free Report ) last posted its earnings results on Tuesday, November 12th. The company reported ($0.
17) earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.
26%. The firm had revenue of $31.73 million for the quarter.
Insider Buying and Selling at Mannatech About Mannatech ( Get Free Report ) Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also Five stocks we like better than Mannatech Do Real Estate Investment Trusts Deserve a Place in Your Portfolio? Super Micro Computer Soars 28%: Is It Really Out of the Woods? How to Read Stock Charts for Beginners Traders Are Flocking Back to Oil: What’s Fueling the Optimism What to Know About Investing in Penny Stocks 3 Hot Stock Trends to Ride Into 2025 Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter ..
